![Full article: Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion Full article: Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion](https://www.tandfonline.com/cms/asset/df5ff46a-017d-418a-bc6d-d6cf5f2c5dbd/icmo_a_444102_f0001_b.jpg)
Full article: Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion
![Comparing Long-Acting Methylphenidate: Concerta vs Jornay PM vs Adhansia XR – Psychiatry Education Forum Comparing Long-Acting Methylphenidate: Concerta vs Jornay PM vs Adhansia XR – Psychiatry Education Forum](https://psychiatryeducationforum.com/wp-content/uploads/2021/11/Copy-of-COMPARING-LONG-ACTING-METHYLPHENIDATE-FORMULATIONS-2.png)
Comparing Long-Acting Methylphenidate: Concerta vs Jornay PM vs Adhansia XR – Psychiatry Education Forum
![Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? | Child and Adolescent ... Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? | Child and Adolescent ...](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1753-2000-3-39/MediaObjects/13034_2009_Article_95_Fig1_HTML.jpg)
Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? | Child and Adolescent ...
![MTS abrupt conversion study design. MTS = methylphenidate transdermal... | Download Scientific Diagram MTS abrupt conversion study design. MTS = methylphenidate transdermal... | Download Scientific Diagram](https://www.researchgate.net/publication/40681125/figure/fig2/AS:289285476503556@1445982440459/MTS-abrupt-conversion-study-design-MTS-methylphenidate-transdermal-system-MPH.png)
MTS abrupt conversion study design. MTS = methylphenidate transdermal... | Download Scientific Diagram
![Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-244X-13-237/MediaObjects/12888_2013_Article_1428_Fig2_HTML.jpg)
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text
![A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - ScienceDirect A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149291820304719-gr2.jpg)